Intraperitoneal chemotherapy for peritoneal metastases of gastric origin: a systematic review and meta-analysis.

Niels A D GuchelaarKazem NasserinejadBianca MostertStijn L W KoolenPieter C van der SluisSjoerd M LagardeBas P L WijnhovenRon H J MathijssenBo Jan Noordman

Published in: The British journal of surgery (2024)

Repeated intraperitoneal chemotherapy, regardless of method of administration, is safe for patients with gastric cancer and peritoneal metastases. Conversion surgery after completion of the intraperitoneal chemotherapy is possible in a subset of patients.

Keyphrases

locally advanced
end stage renal disease
ejection fraction
newly diagnosed
minimally invasive
chronic kidney disease
prognostic factors
squamous cell carcinoma
coronary artery bypass
rectal cancer
coronary artery disease